CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

Clinical trial NCT02424968 · COMPLETED

Trial details

NCT number: NCT02424968
Sponsor: Robert Lowsky
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia B-Cell Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Hodgkin Lymphoma Myelodysplastic Syndrome Myeloproliferative Neoplasm T-Cell Non-Hodgkin Lymphoma

Start date: 2015-06-01
Primary completion: 2020-07-03
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.